Anteris Technologies Global Company Description
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.
Anteris Technologies Global Corp. is based in Toowong, Australia.

Country | United States |
Founded | 1999 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 136 |
CEO | Wayne Paterson |
Contact Details
Address: Toowong Tower Toowong, Delaware 4066 Australia | |
Phone | 61 7 3152 3200 |
Website | anteristech.com |
Stock Details
Ticker Symbol | AVR |
Exchange | Australian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | AU0000088841 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Wayne Geoffrey Paterson | Vice Chairman and Chief Executive Officer |
David St. Denis | President and Director |
Matthew McDonnell | Chief Financial Officer |
Stephen Anthony Denaro | Non-Executive Director and Company Secretary |
Dr. Chris Meduri M.D., M.P.H. | Chief Medical Officer and Member of Medical Advisory Board |